Psilopatis, I.; Sykaras, A.G.; Mandrakis, G.; Vrettou, K.; Theocharis, S.
Patient-Derived Organoids: The Beginning of a New Era in Ovarian Cancer Disease Modeling and Drug Sensitivity Testing. Biomedicines 2023, 11, 1.
https://doi.org/10.3390/biomedicines11010001
AMA Style
Psilopatis I, Sykaras AG, Mandrakis G, Vrettou K, Theocharis S.
Patient-Derived Organoids: The Beginning of a New Era in Ovarian Cancer Disease Modeling and Drug Sensitivity Testing. Biomedicines. 2023; 11(1):1.
https://doi.org/10.3390/biomedicines11010001
Chicago/Turabian Style
Psilopatis, Iason, Alexandros G. Sykaras, Georgios Mandrakis, Kleio Vrettou, and Stamatios Theocharis.
2023. "Patient-Derived Organoids: The Beginning of a New Era in Ovarian Cancer Disease Modeling and Drug Sensitivity Testing" Biomedicines 11, no. 1: 1.
https://doi.org/10.3390/biomedicines11010001
APA Style
Psilopatis, I., Sykaras, A. G., Mandrakis, G., Vrettou, K., & Theocharis, S.
(2023). Patient-Derived Organoids: The Beginning of a New Era in Ovarian Cancer Disease Modeling and Drug Sensitivity Testing. Biomedicines, 11(1), 1.
https://doi.org/10.3390/biomedicines11010001